Population-based patterns of systemic therapy use in liver-limited metastatic colorectal cancer (mCRC)

被引：0
|
作者：
Kellock, Trenton Tyler
Gresham, Gillian
Cheung, Winson Y.
机构：
[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[2] Univ Ottawa, Ottawa, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期
关键词：
D O I：
10.1200/jco.2013.31.4_suppl.576
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
576
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A population-based study of the effect of FDG PET/CT in the management of liver-limited colorectal adenocarcinoma (CRC) metastases
    Ho, Maria Yi
    Parhar, Tarnjit
    Wilson, Don
    Cheung, Winson Y.
    Lim, Howard John
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [22] Treatment patterns and outcomes in metastatic colorectal cancer (mCRC).
    Cartwright, Thomas H.
    Wen, Lonnie Kent
    Harrell, Robyn K.
    Fox, Patricia S.
    Espirito, Janet L.
    Wang, Ed
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [23] Impact of irinotecan and oxaliplatin on overall survival in patients with metastatic colorectal cancer (MCRC): A population-based study
    Lim, H. J.
    Fitzgerald, C.
    Gill, S.
    Melosky, B.
    Speers, C.
    Barnett, J.
    Kennecke, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] Patterns of care and outcomes for young patients (age < 40) with metastatic colorectal cancer (mCRC): Findings from a population-based registry
    Vatandoust, Sina
    Price, Timothy Jay
    Padbury, Rob
    Roder, David
    Beeke, Carol
    Roy, Amltesh
    Townsend, Amanda Rose
    Karapetls, Chrlstos Stellos
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [25] Does “Conversion Chemotherapy” Really Improve Survival in Metastatic Colorectal Cancer Patients with Liver-Limited Disease?
    K. Kataoka
    A. Kanazawa
    S. Iwamoto
    T. Kato
    A. Nakajima
    A. Arimoto
    World Journal of Surgery, 2014, 38 : 936 - 946
  • [26] Does "Conversion Chemotherapy" Really Improve Survival in Metastatic Colorectal Cancer Patients with Liver-Limited Disease?
    Kataoka, K.
    Kanazawa, A.
    Iwamoto, S.
    Kato, T.
    Nakajima, A.
    Arimoto, A.
    WORLD JOURNAL OF SURGERY, 2014, 38 (04) : 936 - 946
  • [27] Colorectal Cancer and Synchronous Liver-limited Metastatic Disease: The final results of the CoSMIC Inception Cohort Study
    Chan, Anthony
    Mason, James
    Siriwardena, Ajith
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [28] Importance of Response to Neoadjuvant Therapy in Patients With Liver-Limited mCRC When the Intent Is Resection and/or Ablation
    Wagman, Lawrence D.
    CLINICAL COLORECTAL CANCER, 2013, 12 (04) : 223 - 232
  • [29] Translating efficacy fi cacy of liver transplantation in liver-limited metastatic colorectal cancer into clinical practice: the TransMet trial
    Germani, M. M.
    Raschzok, N.
    Heinemann, V.
    Modest, D. P.
    ESMO OPEN, 2024, 9 (09)
  • [30] Population-Based Patterns and Factors Associated With Underuse of Palliative Systemic Therapy in Elderly Patients With Metastatic Colon Cancer
    Chan, Matthew
    Hugh-Yeun, Kiara
    Gresham, Gillian
    Speers, Caroline H.
    Kennecke, Hagen F.
    Cheung, Winson Y.
    CLINICAL COLORECTAL CANCER, 2017, 16 (02) : 147 - 153
12345